scholarly journals Sexual desire disorder in men

2019 ◽  
pp. 33-35
Keyword(s):  
Sexual Dysfunction ◽  
Sexual Function ◽  
Sexual Desire ◽  
Sexual Functioning ◽  
Sexual Life ◽  
Sexual Disorders ◽  
Hypoactive Sexual Desire Disorder ◽  
Multiple Factors ◽  
Sexual Dissatisfaction ◽  
Desire Disorder

Hypoactive sexual desire disorder in men may occur in the context of poor sexual functioning, secondary to sexual dysfunction or a state of sexual dissatisfaction, or may may correspond to poor functioning of the couple. Thus, these multiple factors can generate a hypoactive sexual desire issue. The disorder of desire may also mean cognitions and / or persistently or recurrently reduced(absent) sexual/ erotic fantasies. Worldwide prevalence of sexual desire disorder in men is occasionally 6% for those 8-24 years old; significantly 41% for those 66-74 years old, and persistently 1,8% for those 16-44 years old. The disorder may emerge from the beginning of the sexual life or begin after a period of relatively normal sexual function. Keywords: hypoactive sexual desire disorder, s-on, therapy, testing, evaluation, sexual disorders.

Sexual Dysfunction: Hypoactive Sexual Desire Disorder

2018 ◽  
Author(s):  
John E Buster
Keyword(s):  
Side Effects ◽  
Sexual Dysfunction ◽  
Sexual Desire ◽  
Family Relationships ◽  
Selective Serotonin Reuptake Inhibitors ◽  
Life Quality ◽  
Premenopausal Women ◽  
Reproductive Hormones ◽  
Hypoactive Sexual Desire Disorder ◽  
Desire Disorder

Healthy female sexual functioning is driven by sexual desire. Sexual desire, traditionally defined as sexual thoughts and fantasies, is a natural life force and an art form affecting all aspects of a woman’s interpersonal and professional life. Virtually, all diagnostic categories of female sexual dysfunction, including arousal disorder, anorgasmia, and sexual pain disorder are linked to, caused by, or aggravated by loss of sexual desire. Decreased sexual desire is a diagnosis (hypoactive sexual desire disorder, HSDD) with its own International Classification of Diseases code (F52.0).. Impact is often subtle. HSDD may express as seemingly unrelated emotional disturbances that degrade life quality in family relationships, in the workplace, or both. For some women, it is severely distracting. The diagnosis of HSDD is made when symptoms are sufficient to cause distress. In older women, HSDD is heavily impacted by menopause-associated withdrawal of reproductive hormones, particularly testosterone and estradiol. HSDD greatly improves with transdermal replacement of these steroids. Side effects of transdermal hormones are minimal but response can be gratifying. In premenopausal women, HSDD behaves more as a psychoendocrine disorder that is responsive in some patients to flibanserin, a nonhormonal 5-HT1A receptor agonist. Side effects of flibanserin are significant but manageable. This review contains 12 figures, 6 tables, and  references. Key Words: estradiol, flibanserin, hypoactive sexual desire disorder, menopause, selective serotonin reuptake inhibitors, sexual desire, sexuality, testosterone, transdermal, women

Male Sexual Function and Dysfunction (DRAFT)

2018 ◽  
Author(s):  
Jeffrey A. Albaugh
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Sexual Function ◽  
Premature Ejaculation ◽  
Lifestyle Modification ◽  
Treatment Options ◽  
Hypoactive Sexual Desire Disorder ◽  
Delayed Ejaculation ◽  
Male Sexual Function ◽  
Desire Disorder

Sexual dysfunction is a common and frustrating problem in men that is often under reported and under treated. Sexual dysfunction issues identified by men may include hypoactive sexual desire disorder/lack of libido, premature ejaculation, delayed ejaculation, erectile dysfunction and/or Peyronie’s disease. This chapter covers information on how normal sexual function occurs and some of the etiologic factors leading to sexual dysfunction. Understanding each individual patient and their goals for sexual health can lead to identifying and addressing sexual issues effectively. Information is provided about some of the traditional medical treatment options typically used to treat men with common sexual problems. In addition, some lifestyle modification and psychological approaches to treating sexual dysfunction are discussed.

Pharmacotherapy of male sexual dysfunction: From serendipidity to rational approach to treatment

2011 ◽  
Vol 26 (S2) ◽  
pp. 2035-2035
Author(s):  
R. Balon
Keyword(s):  
Erectile Dysfunction ◽  
Sexual Dysfunction ◽  
Sexual Desire ◽  
Rational Approach ◽  
Sexual Dysfunctions ◽  
Hypoactive Sexual Desire Disorder ◽  
Therapeutic Modalities ◽  
Male Sexual Dysfunction ◽  
Level I ◽  
Desire Disorder

Pharmacotherapy of male sexual dysfunction(s) has developed similar to pharmacotherapy of depression. Some of the treatments for male sexual dysfunctions have been used based on old observations or myths (e.g., so called aphrodisiacs), some based on intuition (e.g. hormones for hypoactive sexual desire disorder), and some were discovered serendipitously (e.g., PDE-5 inhibitors). New, “me-too” PDE-5 inhibitors (e.g., avanafil, mirodenafil, udenafil) are being developed, similar to the development of new antidepressants. A rational approach to pharmacotherapy of hypoactive sexual desire disorder, male erectile disorder and premature ejaculation is being conceptualized (no pharmacotherapy for delayed orgasm is available at present). For instance, the approach to treatment of erectile dysfunction has been frequently staged into three levels (Level I: psychotherapy, oral preparations including hormones, vacuum erectile devices; Level II: intraurethral and intracorporeal application of various preparations; Level III: microsurgery, prosthesis). The management of pharmacotherapy failures, as well as combination of approaches to sexual dysfunctions, (e.g., PDE-5 and hormones for erectile dysfunction) have not been systematically studied. This presentation discusses a rational approach to staging pharmacotherapy of male sexual dysfunction and will also discuss potential combination of therapeutic modalities, especially for treatment resistant cases.

Sign in / Sign up

Export Citation Format

Share Document